APA (7th ed.) Citation

Bahig, H., Aubin, F., Stagg, J., Gologan, O., Ballivy, O., Bissada, E., . . . Wong, P. (2019). Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma. BMC Cancer, 19(1), 1. https://doi.org/10.1186/s12885-019-5266-4

Chicago Style (17th ed.) Citation

Bahig, Houda, et al. "Phase I/II Trial of Durvalumab Plus Tremelimumab and Stereotactic Body Radiotherapy for Metastatic Head and Neck Carcinoma." BMC Cancer 19, no. 1 (2019): 1. https://doi.org/10.1186/s12885-019-5266-4.

MLA (9th ed.) Citation

Bahig, Houda, et al. "Phase I/II Trial of Durvalumab Plus Tremelimumab and Stereotactic Body Radiotherapy for Metastatic Head and Neck Carcinoma." BMC Cancer, vol. 19, no. 1, 2019, p. 1, https://doi.org/10.1186/s12885-019-5266-4.